AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
1min snip
#384 Updates in Chronic Kidney Disease with Dr. Joel Topf
The Curbsiders Internal Medicine Podcast
The Benefits of SGLT2 Inhibitors in the Treatment of CKD
AKI is a potential risk with the use of SGLT2 inhibitors, but the risk is lower when taken with DAPA CKD./nThe timing for starting a new ACE inhibitor for getting a metabolic panel is usually two to four weeks.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode